Marketing Research and Consulting for the Pharma and Biotech Industries
Perspectives
The Yin of Marketing Research
Most people think of marketing research as being about information, data, numbers, etc. I don’t. Marketing research is about understanding of customers and converting understanding into a story, images, charts that management will remember, re-use and re-purpose. As marketing research ...
June 25th, 2010 Read MoreThe Next Five Years Will Redefine Pharma and Pharma MR
The world of pharma is undergoing dramatic change and those that adapt to these changes the most quickly will thrive and those who don’t will likely not survive. The same is true for Pharma MR. How can we expect Pharma ...
May 16th, 2010 Read MoreChange Isn’t Just Smart, It’s a Mandate
The pharmaceutical and biotech industries continue to undergo dramatic change. What worked in the past may no longer work in the future. For those in marketing research, this change presents a rare opportunity. We have the potential to break away ...
March 28th, 2010 Read MoreMarketing Research: Confidence vs. Conviction
The difference between a crisis and an opportunity is often how quickly you learn about it and take the appropriate action: progress over perfect. Getting imperfect information assembled and disseminated quickly is often far more valuable than conveying more perfect ...
July 29th, 2009 Read MoreKim Slocum Quoted in “Obamaceuticals”, PharmaVOICE
Click Here to view this article. (PDF Format) ...
July 2nd, 2009 Read MoreThere are no do-overs
There are no do-overs when presenting to senior management. From thirty years’ worth of experience presenting information to the senior executives in pharma and biotech, here’s what they want: Synthesis, not analysis Clarity of thinking Concise presentations Actionable conclusions ...
May 11th, 2009 Read MoreHealth Care – Rational or Rationed
That was the title of a talk delivered back in 1996 by Dr. George Poste. At that time, George had recently retired from his position as head of Research for SmithKline Beecham (pre-Glaxo). I found the talk fascinating because it ...
April 28th, 2009 Read MoreHealogix CEO Describes a Fundamental Shift in the Industry
Using the metaphor of a poker game, Harris Kaplan clearly articulates the steps that pharmaceutical marketers must take in order to build better (i.e. more commercially successful) drugs in today’s more challenging market environment. Payer, patient AND physician needs must be taken into account if a drug is to find maximum uptake. The information needs of doing so are daunting. Harris describes a framework for developing the value proposition before the drug enters clinical trials. ...
February 18th, 2009 Read MoreShift Happens!
The last twenty years have witnessed dramatic growth in the pharmaceutical industry. But as is the case with all business cycles, market and environmental conditions change, and the pharmaceutical industry has had a longer ride than most. The surest sign ...
December 1st, 2008 Read MoreHuge Marketing Spend is NOT a Strategy
Surprised that pharma companies have the lowest P/E ratios in 20 years? According to a recent Bernstein research report, more than half a drugmaker’s market cap reflects the strength of their pipeline, more so than their operating results. In this ...
October 21st, 2008 Read MoreOffice: 215.863.8160 | Fax: 215.830.5051 | Email: info@healogix.com